Ro 22-1319, a novel pyrroloisoquinoline compound, was identified as a potential antipsychotic agent in a rat discrete avoidance procedure that is highly specific for such agents. Results in this test are highly correlated with the clinical potency of all types of antipsychotic agents. The avoidance-
Pharmacological effects of HR 375: A new potential antipsychotic agent
✍ Scribed by Franz J. Hock; Hansjörg Kruse; Hermann J. Gerhards; Elmar Konz
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 620 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The 1 -(2-hydroxy-1 -phenylethyl)-imidazole derivative Hoe 249 has a profile which suggests the compound is a promising candidate for clinical evaluation as an antidepressant drug. In pharmacological tests commonly considered predictive of antidepressant activity, e.g., reserpine-and tetrabenazine-a
The new potential antipsychotic drug BMY 20661 was subjected to a series of electrophysiological tests to determine its effects on midbrain dopamine (DA) neurons in the rat substantia nigra pars compacta (A9) and ventral tegmental area (AlO). Acute intravenous (i.v.) administration of BMY 20661 exer